Clinical Trial Details

Trial ID: L0595
Source ID: IRCT2015102624725N1
Associated Drug: Vitamin D
Title: Evaluation of vitamin D administration in non-alchoholic fatty liver disease(NAFLD)
Acronym: --
Status: Not Recruiting
Study Results: No Results Available
Results: --
Conditions: Nonalcoholic fatty liver disease (NAFLD). <br>Nonalcoholic fatty liver disease (NAFLD;Nonalcoholic fatty liver disease (NAFLD
Interventions: Intervention 1: Intervention:administration of vitamin D pearl and life style modification. Intervention 2: Control: lifestyle modification.;Treatment - Drugs;Lifestyle;Intervention:administration of vitamin D pearl and life style modification;Control: li
Outcome Measures: The level of aminotransferases. Timepoint: 3th and 6th month. Method of measurement: biochemical.;Fibroscan and BMI. Timepoint: 3th and 6th month for BMI and 6th month for fibroscan. Method of measurement: fibroscan and anthropometric measurement( kg/m2).nan
Sponsor/Collaborators: Vice Chancellor for Research Mazandaran University of Medical Sciences
Gender: All
Age: no limitno limit
Phases: Not applicable
Enrollment: 40
Study Type: interventional
Study Designs: Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Single, Purpose: Treatment, Other design features: Two groups will be matched with random number table.
Start Date: 03/01/2016
Completion Date: --
Results First Posted: --
Last Update Posted: 22 February 2018
Locations: Iran (Islamic Republic of)
URL: http://en.irct.ir/trial/20811